Micropep Technologies is a technology company.
Micropep Technologies has raised $53.0M across 4 funding rounds.
Micropep Technologies has raised $53.0M in total across 4 funding rounds.
Micropep Technologies has raised $53.0M in total across 4 funding rounds.
Micropep Technologies's investors include Soffinova Partners.
Micropep Technologies is a French agrobiotech company developing peptide-based biological crop protection solutions using micropeptides—short natural protein molecules that regulate plant genes and proteins to enhance resistance to pathogens, combat weeds, and improve plant health.[1][2][3] Founded in 2016 as a spin-out from Toulouse University and CNRS, it serves farmers worldwide by addressing climate change impacts on agriculture through sustainable alternatives to chemical pesticides, with products targeting resistant weeds and crop stressors.[1][2][5] The company has raised over $60 million in funding, including a $40 million Series B closed in 2024 with investors like Corteva, Sparkfood, Sofinnova, and Irdi Soridec, employs around 45-53 people, and is expanding in the US while generating reported revenue between $405,000 and $21.2 million.[1][2][4]
Its proprietary discovery platform integrates AI, bioproduction, and delivery tech to identify and formulate micropeptides for agronomic challenges, with a broad pipeline and partnerships like FMC for commercialization.[2][3][5] This positions Micropep as a leader in biologicals, riding demand for eco-friendly crop protection amid regulatory pressures on synthetics.
Micropep Technologies originated in 2016 in Toulouse, France, as a spin-out from the LRSV plant research lab at CNRS and Toulouse University, a hub for AgriTech innovation.[1][2] Co-founder Thomas Laurent, with a background in business strategy consulting, entrepreneurship, and tech transfer, partnered with scientists Jean-Philippe Combier (scientific advisor) and Mikael Courbot (current CTO) after discovering their breakthrough in micropeptide technology—naturally occurring peptides derived from micro-RNAs that regulate plant gene expression.[1][2][5]
Early traction came from institutional support and seed funding, evolving with Series A and B rounds starting in 2018 from Sofinnova and Irdi Soridec, culminating in the oversubscribed $40M Series B in 2024.[1][2] Pivotal moments include US expansion in 2022, key hires like CEO Georg Goeres, and partnerships such as the 2022 FMC collaboration for biological solutions, humanizing the team's mission-driven push from lab discovery to global farmer impact.[2][3][5]
Micropep rides the biological crop protection wave, fueled by climate change threats to food security, herbicide resistance crises, and EU/US regulations phasing out synthetic chemicals.[2][3][5] Timing is ideal as agbiologicals market grows amid falling peptide production costs, enabling pharma-like precision in farming—Micropep's micropeptides offer targeted, transient gene regulation without genetic modification.[1][5]
Market forces like rising demand for sustainable ag (e.g., Corteva's Catalyst investments) favor them, while their platform influences the ecosystem by accelerating biological innovation, partnering with incumbents like FMC, and expanding from Europe to US trials.[3][5] This helps democratize resilient farming, countering yield losses from weeds and stressors in a $200B+ crop protection sector.
Micropep is poised for commercialization milestones, with first micropeptide products nearing market via FMC and Corteva partnerships, potentially launching in 2025-2026 amid pipeline expansion.[3][5] Trends like AI-ag integration, biologicals regulatory fast-tracking, and climate-adaptive crops will propel growth, evolving their influence from Toulouse spin-out to global ag leader.
Expect scaled US operations, more deals with majors, and revenue ramps as formulations hit fields—cementing their role in sustainable agriculture's future, true to their mission of planet-protecting innovation.[2][3]
Micropep Technologies has raised $53.0M across 4 funding rounds. Most recently, it raised $29.0M Series B in July 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2024 | $29.0M Series B | Soffinova Partners | |
| Jun 1, 2022 | $9.0M Series A | Soffinova Partners | |
| Jul 1, 2021 | $10.0M Series A | Soffinova Partners | |
| Mar 1, 2018 | $5.0M Series A | Soffinova Partners |